IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.720
-0.020 (-1.15%)
At close: Mar 6, 2026, 4:00 PM EST
1.730
+0.010 (0.58%)
After-hours: Mar 6, 2026, 5:26 PM EST

IN8bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1719605782-
Market Cap Growth
-18.97%-68.78%5.36%-31.23%--
Enterprise Value
9.0710.9241.834347.210
Last Close Price
1.727.7241.4069.30131.70-
PE Ratio
--0.45-1.38-1.70-2.99-
PB Ratio
0.601.292.402.492.16-
P/TBV Ratio
0.460.951.652.131.15-
P/FCF Ratio
--0.77-2.50-2.04-5.97-
P/OCF Ratio
--0.77-2.56-2.35-6.10-
EV/EBITDA Ratio
--0.39-1.52-1.57-3.41-
EV/EBIT Ratio
--0.36-1.39-1.51-3.22-
EV/FCF Ratio
--0.45-1.75-1.55-3.42-
Debt / Equity Ratio
0.140.230.140.200.050.01
Debt / EBITDA Ratio
-0.16-0.18-0.18-0.21-0.17-0.02
Debt / FCF Ratio
-0.20-0.21-0.20-0.21-0.17-0.02
Net Debt / Equity Ratio
-0.59-0.42-0.66-0.54-0.911.08
Net Debt / EBITDA Ratio
0.430.220.600.452.502.10
Net Debt / FCF Ratio
0.530.250.690.442.512.50
Quick Ratio
6.283.613.953.1216.417.00
Current Ratio
6.914.084.573.8217.287.05
Return on Equity (ROE)
-149.33%-154.44%-125.90%-93.64%-51.87%-95.21%
Return on Assets (ROA)
-109.56%-111.38%-89.91%-75.79%-46.42%-77.65%
Return on Invested Capital (ROIC)
-298.42%-359.44%-316.33%-407.56%-716.53%-4376.98%
Return on Capital Employed (ROCE)
-125.48%-131.83%-108.07%-84.90%-50.26%-90.93%
Earnings Yield
-122.98%-221.50%-72.46%-58.87%-33.49%-
FCF Yield
-87.12%-130.47%-40.08%-49.08%-16.76%-
Buyback Yield / Dilution
-100.21%-80.78%-46.61%-16.94%-44.10%-
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q